Severity in dysmorphophobia: description of two cases

Many authors consider dysmorphophobia (body dysmorphic disorder) as a disorder within the obsessivecompulsive spectrum. Both the phenomenological features and response to serotonergic drugs support this idea. Nonetheless, it is included in the somatoform disorder section within the main diagnostic c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Actas españolas de psiquiatría 2003-05, Vol.31 (3), p.168-170
Hauptverfasser: García-Parajuá, P, Martínez Vigo, M, Ovejero García, S, Caballero Martínez, L
Format: Artikel
Sprache:spa
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 170
container_issue 3
container_start_page 168
container_title Actas españolas de psiquiatría
container_volume 31
creator García-Parajuá, P
Martínez Vigo, M
Ovejero García, S
Caballero Martínez, L
description Many authors consider dysmorphophobia (body dysmorphic disorder) as a disorder within the obsessivecompulsive spectrum. Both the phenomenological features and response to serotonergic drugs support this idea. Nonetheless, it is included in the somatoform disorder section within the main diagnostic classifications. Two cases of dysmorphophobia are presented. Both patients were admitted to the psychiatric unit due to secondary complicacions of the disorder. After reviewing the available literature, we discuss the severity that this condition may reach. Comorbid disorders and other complications such as suicide attempts are often present. In addition patients usually hide their suffering. Furthemore, it is important for clinicians to assess the body dysmorphic disorder carefully and rule it out.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_73307255</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73307255</sourcerecordid><originalsourceid>FETCH-LOGICAL-p139t-c22c8f320c52b52ee54300de94f27b13b85ac490ed2535a01ba6b7bd53dc4f603</originalsourceid><addsrcrecordid>eNo1j81KxDAYRbNQnHHGV5Cs3BWSL8mkdSeDfzDgQmdd8vMVI21Tk1bp21twBi7czeFc7gVZcy6qooJSr8h1zl-M8VKCuiIrDloDk3pN1Dv-YArjTENP_Zy7mIbPuMQGc089ZpfCMIbY09jQ8TdSZzLmLblsTJvx5tQbcnx6_Ni_FIe359f9w6EYluWxcACubAQwp8AqQFRSMOaxkg1oy4UtlXGyYuhBCWUYt2ZntfVKeCebHRMbcvfvHVL8njCPdReyw7Y1PcYp11oIpkGpBbw9gZPt0NdDCp1Jc30-Kv4A245N5Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73307255</pqid></control><display><type>article</type><title>Severity in dysmorphophobia: description of two cases</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>García-Parajuá, P ; Martínez Vigo, M ; Ovejero García, S ; Caballero Martínez, L</creator><creatorcontrib>García-Parajuá, P ; Martínez Vigo, M ; Ovejero García, S ; Caballero Martínez, L</creatorcontrib><description>Many authors consider dysmorphophobia (body dysmorphic disorder) as a disorder within the obsessivecompulsive spectrum. Both the phenomenological features and response to serotonergic drugs support this idea. Nonetheless, it is included in the somatoform disorder section within the main diagnostic classifications. Two cases of dysmorphophobia are presented. Both patients were admitted to the psychiatric unit due to secondary complicacions of the disorder. After reviewing the available literature, we discuss the severity that this condition may reach. Comorbid disorders and other complications such as suicide attempts are often present. In addition patients usually hide their suffering. Furthemore, it is important for clinicians to assess the body dysmorphic disorder carefully and rule it out.</description><identifier>ISSN: 1139-9287</identifier><identifier>PMID: 12772047</identifier><language>spa</language><publisher>Spain</publisher><subject>Adult ; Antipsychotic Agents - therapeutic use ; Depressive Disorder - etiology ; Female ; Humans ; Risperidone - therapeutic use ; Severity of Illness Index ; Somatoform Disorders - drug therapy ; Somatoform Disorders - psychology ; Suicide, Attempted - psychology</subject><ispartof>Actas españolas de psiquiatría, 2003-05, Vol.31 (3), p.168-170</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12772047$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>García-Parajuá, P</creatorcontrib><creatorcontrib>Martínez Vigo, M</creatorcontrib><creatorcontrib>Ovejero García, S</creatorcontrib><creatorcontrib>Caballero Martínez, L</creatorcontrib><title>Severity in dysmorphophobia: description of two cases</title><title>Actas españolas de psiquiatría</title><addtitle>Actas Esp Psiquiatr</addtitle><description>Many authors consider dysmorphophobia (body dysmorphic disorder) as a disorder within the obsessivecompulsive spectrum. Both the phenomenological features and response to serotonergic drugs support this idea. Nonetheless, it is included in the somatoform disorder section within the main diagnostic classifications. Two cases of dysmorphophobia are presented. Both patients were admitted to the psychiatric unit due to secondary complicacions of the disorder. After reviewing the available literature, we discuss the severity that this condition may reach. Comorbid disorders and other complications such as suicide attempts are often present. In addition patients usually hide their suffering. Furthemore, it is important for clinicians to assess the body dysmorphic disorder carefully and rule it out.</description><subject>Adult</subject><subject>Antipsychotic Agents - therapeutic use</subject><subject>Depressive Disorder - etiology</subject><subject>Female</subject><subject>Humans</subject><subject>Risperidone - therapeutic use</subject><subject>Severity of Illness Index</subject><subject>Somatoform Disorders - drug therapy</subject><subject>Somatoform Disorders - psychology</subject><subject>Suicide, Attempted - psychology</subject><issn>1139-9287</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j81KxDAYRbNQnHHGV5Cs3BWSL8mkdSeDfzDgQmdd8vMVI21Tk1bp21twBi7czeFc7gVZcy6qooJSr8h1zl-M8VKCuiIrDloDk3pN1Dv-YArjTENP_Zy7mIbPuMQGc089ZpfCMIbY09jQ8TdSZzLmLblsTJvx5tQbcnx6_Ni_FIe359f9w6EYluWxcACubAQwp8AqQFRSMOaxkg1oy4UtlXGyYuhBCWUYt2ZntfVKeCebHRMbcvfvHVL8njCPdReyw7Y1PcYp11oIpkGpBbw9gZPt0NdDCp1Jc30-Kv4A245N5Q</recordid><startdate>200305</startdate><enddate>200305</enddate><creator>García-Parajuá, P</creator><creator>Martínez Vigo, M</creator><creator>Ovejero García, S</creator><creator>Caballero Martínez, L</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200305</creationdate><title>Severity in dysmorphophobia: description of two cases</title><author>García-Parajuá, P ; Martínez Vigo, M ; Ovejero García, S ; Caballero Martínez, L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p139t-c22c8f320c52b52ee54300de94f27b13b85ac490ed2535a01ba6b7bd53dc4f603</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>spa</language><creationdate>2003</creationdate><topic>Adult</topic><topic>Antipsychotic Agents - therapeutic use</topic><topic>Depressive Disorder - etiology</topic><topic>Female</topic><topic>Humans</topic><topic>Risperidone - therapeutic use</topic><topic>Severity of Illness Index</topic><topic>Somatoform Disorders - drug therapy</topic><topic>Somatoform Disorders - psychology</topic><topic>Suicide, Attempted - psychology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>García-Parajuá, P</creatorcontrib><creatorcontrib>Martínez Vigo, M</creatorcontrib><creatorcontrib>Ovejero García, S</creatorcontrib><creatorcontrib>Caballero Martínez, L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Actas españolas de psiquiatría</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>García-Parajuá, P</au><au>Martínez Vigo, M</au><au>Ovejero García, S</au><au>Caballero Martínez, L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Severity in dysmorphophobia: description of two cases</atitle><jtitle>Actas españolas de psiquiatría</jtitle><addtitle>Actas Esp Psiquiatr</addtitle><date>2003-05</date><risdate>2003</risdate><volume>31</volume><issue>3</issue><spage>168</spage><epage>170</epage><pages>168-170</pages><issn>1139-9287</issn><abstract>Many authors consider dysmorphophobia (body dysmorphic disorder) as a disorder within the obsessivecompulsive spectrum. Both the phenomenological features and response to serotonergic drugs support this idea. Nonetheless, it is included in the somatoform disorder section within the main diagnostic classifications. Two cases of dysmorphophobia are presented. Both patients were admitted to the psychiatric unit due to secondary complicacions of the disorder. After reviewing the available literature, we discuss the severity that this condition may reach. Comorbid disorders and other complications such as suicide attempts are often present. In addition patients usually hide their suffering. Furthemore, it is important for clinicians to assess the body dysmorphic disorder carefully and rule it out.</abstract><cop>Spain</cop><pmid>12772047</pmid><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1139-9287
ispartof Actas españolas de psiquiatría, 2003-05, Vol.31 (3), p.168-170
issn 1139-9287
language spa
recordid cdi_proquest_miscellaneous_73307255
source MEDLINE; Alma/SFX Local Collection
subjects Adult
Antipsychotic Agents - therapeutic use
Depressive Disorder - etiology
Female
Humans
Risperidone - therapeutic use
Severity of Illness Index
Somatoform Disorders - drug therapy
Somatoform Disorders - psychology
Suicide, Attempted - psychology
title Severity in dysmorphophobia: description of two cases
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T11%3A15%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Severity%20in%20dysmorphophobia:%20description%20of%20two%20cases&rft.jtitle=Actas%20espa%C3%B1olas%20de%20psiquiatr%C3%ADa&rft.au=Garc%C3%ADa-Paraju%C3%A1,%20P&rft.date=2003-05&rft.volume=31&rft.issue=3&rft.spage=168&rft.epage=170&rft.pages=168-170&rft.issn=1139-9287&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E73307255%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73307255&rft_id=info:pmid/12772047&rfr_iscdi=true